Exhaled breath condensate biomarkers in asbestos-related lung disorders

Respiratory Medicine

Volumn 103, Issue 8, 2009, Pages 1091-1097

  Chow, Sharron ^a,c   Campbell, Charlotte ^b   Sandrini, Alessandra ^a,b   Thomas, Paul S ^c   Johnson, Anthony R ^a   Yates, Deborah H ^a,b  

^a Research and Education Unit   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Asbestos; Exhaled breath condensate; Exhaled nitric oxide; Oxidative stress

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTANE; ASBESTOS; BIOLOGICAL MARKER; CARBON MONOXIDE; HYDROGEN PEROXIDE; NITRIC OXIDE; NITROGEN OXIDE; PROTEIN;

AGED; ARTICLE; ASBESTOSIS; BREATH ANALYSIS; CONTROLLED STUDY; EXPIRED AIR; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PH; PLEURA PLAQUE; PLEURA THICKENING; PRIORITY JOURNAL;

AGED; ASBESTOS; ASBESTOSIS; BIOLOGICAL MARKERS; DINOPROST; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PROGNOSIS; TYROSINE;

EID: 67649117842     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.04.009     Document Type: Article

References (45)

1. Berry G., Musk A.W., De Klerk N.H., et al. Predictions of mortality from mesothelioma. Occup Environ Med 60 (2003) 458
2. Clements M., Berry G., Shi J., et al. Projected mesothelioma incidence in men in New South Wales. Occup Environ Med 64 (2007) 747-752
3. Stayner L.T., Kuempel E., Gilbert S., et al. An epidemiologic study of the role of chrysotile asbestos fiber dimensions in determining respiratory disease risk in exposed workers. Occup Environ Med (2007)
4. Beckett W.S. Shipyard workers and asbestos: a persistent and international problem. Occup Environ Med 64 (2007) 639-641
5. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 170 (2004) 691-715
6. Yates D.H., Browne K., Stidolph P.N., et al. Asbestos-related bilateral diffuse pleural thickening: natural history of radiographic and lung function abnormalities. Am J Respir Crit Care Med 153 (1996) 301-306
7. Kamp D.W., and Weitzman S.A. The molecular basis of asbestos induced lung injury. Thorax 54 (1999) 638-652
8. Kharitonov S.A., Yates D., Robbins R.A., et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343 (1994) 133-135
9. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171 (2005) 912-930
10. Sandrini A., Johnson A.R., Thomas P.S., et al. Fractional exhaled nitric oxide concentration is increased in asbestosis and pleural plaques. Respirology 11 (2006) 325-329
11. Lehtonen H., Oksa P., Lehtimaki L., et al. Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis. Thorax 62 (2007) 602-607
12. Paredi P., Kharitonov S.A., Loukides S., et al. Exhaled nitric oxide is increased in active fibrosing alveolitis. Chest 115 (1999) 1352-1356
13. Horvath I., Hunt J., Barnes P.J., et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26 (2005) 523-548
14. Jackson A.S., Sandrini A., Campbell C., et al. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med 175 (2007) 222-227
15. Cepelak I., and Dodig S. Exhaled breath condensate: a new method for lung disease diagnosis. Clin Chem Lab Med 45 (2007) 945-952
16. Vallyathan V., Mega J.F., Shi X., et al. Enhanced generation of free radicals from phagocytes induced by mineral dusts. Am J Respir Cell Mol Biol 6 (1992) 404-413
17. Goodglick L.A., and Kane A.B. Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo. Cancer Res 50 (1990) 5153-5163
18. Miller M.R., Crapo R., Hankinson J., et al. Standardization of spirometry. Eur Respir J 26 (2005) 319-338
19. Cotes J.E., Chinn D.J., Quanjer P.H., et al. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16 (1993) 41-52
20. Beckmann J.S., Ye Y.Z., Anderson P.G., et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375 (1994) 81-88
21. Montuschi P., Kharitonov S.A., Ciabattoni G., et al. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 55 (2000) 205-209
22. Vaughan J., Ngamtrakulpanit L., Pajewski T.N., et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 22 (2003) 889-894
23. Piipari R., Piirila P., Keskinen H., et al. Exhaled nitric oxide in specific challenge tests to assess occupational asthma. Eur Respir J 20 (2002) 1532-1537
24. Pelclova D., Fenclova Z., Kacer P., et al. Arachidonic acid derivatives in the exhaled breath condensate in pneumoconioses and their correlation with individual factors. Chemicke Listy 101 (2007) s144-s146
25. Pelclova D., Fenclova Z., Kacer P., et al. Exhaled breath condensate in asbestos exposure. Chest 128 (2005) 345S-346S
26. Peterson M.W., Walter M.E., and Gross T.J. Asbestos directly increases lung epithelial permeability. Am J Physiol 265 (1993) L308-L317
27. Kinnula V.L. Oxidant and antioxidant mechanisms of lung disease caused by asbestos fibres. Eur Respir J 14 (1999) 706-716
28. Mossman B.T., and Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 157 (1998) 1666-1680
29. Liu J.Y., Brass D.M., Hoyle G.W., et al. TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol 153 (1998) 1839-1847
30. Liu J.Y., Morris G.F., Lei W.H., et al. Rapid activation of PDGF-A and -B expression at sites of lung injury in asbestos-exposed rats. Am J Respir Cell Mol Biol 17 (1997) 129-140
31. Kharitonov S.A., and Barnes P.J. Exhaled markers of inflammation. Curr Opin Allergy Clin Immunol 1 (2001) 217-224
32. Hunt J.F., Fang K., Malik R., et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 161 (2000) 694-699
33. + in never and current smokers. Respir Med 102 (2008) 457-463
34. Garey K.W., Neuhauser M.M., Robbins R.A., et al. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 125 (2004) 22-26
35. Kharitonov S.A., Yates D.H., Chung K.F., et al. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 9 (1996) 196-201
36. Kharitonov S.A., and Barnes P.J. Effects of corticosteroids on noninvasive biomarkers of inflammation in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 1 (2004) 191-199
37. Van Hoydonck P.G., Wuyts W.A., Vanaudenaerde B.M., et al. Quantitative analysis of 8-isoprostane and hydrogen peroxide in exhaled breath condensate. Eur Respir J 23 (2004) 189-192
38. Rosias P.P., Robroeks C.M., Kester A., et al. Biomarker reproducibility in exhaled breath condensate collected with different condensers. Eur Respir J 31 (2008) 934-942
39. Liu J., Conrad D.H., Chow S., et al. Collection devices influence the constituents of exhaled breath condensate. Eur Respir J 30 (2007) 807-808
40. Prieto L., Ferrer A., Palop J., et al. Differences in exhaled breath condensate pH measurements between samples obtained with two commercial devices. Respir Med 101 (2007) 1715-1720
41. Uasuf C.G., Jatakanon A., James A., et al. Exhaled carbon monoxide in childhood asthma. J Pediatr 135 (1999) 569-574
42. Psathakis K., Mermigkis D., Papatheodorou G., et al. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur J Clin Invest 36 (2006) 362-367
43. Ojoo J.C., Mulrennan S.A., Kastelik J.A., et al. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax 60 (2005) 22-26
44. Effros R., Casaburi R., Su J., et al. The effects of volatile salivary acids and bases on exhaled breath condensate pH. Am J Respir Crit Care Med 173 (2006) 386-392
45. Hunt J. Airway acidification: interactions with nitrogen oxides and airway inflammation. Curr Allergy Asthma Rep 6 (2006) 47-52